We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$180M
Cap. Flow %
92.65%
Top 10 Hldgs %
56.76%
Holding
117
New
116
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$30.5M
2
ARWR icon
Arrowhead Research
ARWR
+$15.5M
3
ARCT icon
Arcturus Therapeutics
ARCT
+$15.4M
4
CLSD
Clearside Biomedical
CLSD
+$7.63M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$6.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.63%
2 Technology 6.05%
3 Communication Services 5.12%
4 Financials 3.37%
5 Consumer Staples 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
26
United Therapeutics
UTHR
$22B
$1.88M 0.97%
+10,500
New +$2M
ATRA icon
27
Atara Biotherapeutics
ATRA
$76.9M
$1.82M 0.93%
+4,676
New +$1.67M
RETA
28
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.78M 0.92%
+12,600
New +$1.42M
ONCT
29
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.71M 0.88%
+18,000
New +$2.14M
MTTR
30
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$1.6M 0.82%
+99,000
New +$1.34M
IDYA icon
31
IDEAYA Biosciences
IDYA
$3.47B
$1.45M 0.75%
+69,200
New +$1.42M
EIGR
32
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.35M 0.69%
+5,283
New +$1.32M
KRYS icon
33
Krystal Biotech
KRYS
$9.64B
$1.3M 0.67%
+19,075
New +$1.33M
SURF
34
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.27M 0.65%
+170,500
New +$1.31M
BTAI icon
35
BioXcel Therapeutics
BTAI
$26M
$1.22M 0.63%
+2,625
New +$1.43M
MRKR icon
36
Marker Therapeutics
MRKR
$19M
$1.17M 0.6%
+42,000
New +$1.11M
MRNA icon
37
Moderna
MRNA
$22.5B
$1.06M 0.54%
+4,500
New +$804K
MDNA
38
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$1.05M 0.54%
+350,000
New +$1.29M
ANVS icon
39
Annovis Bio
ANVS
$79.6M
$1.03M 0.53%
+12,000
New +$554K
KALA icon
40
KALA BIO
KALA
$13.6M
$1.01M 0.52%
+76
New +$1.19M
HSDT icon
41
Solana Company
HSDT
$100M
$1M 0.51%
+2
New +$1.19M
RDHL
42
Redhill Biopharma
RDHL
$4.07M
$964K 0.5%
+140
New +$966K
AXSM icon
43
Axsome Therapeutics
AXSM
$11B
$911K 0.47%
+13,500
New +$810K
SLV icon
44
iShares Silver Trust
SLV
$29.9B
$872K 0.45%
+36,000
New +$892K
RLMD icon
45
Relmada Therapeutics
RLMD
$571M
$791K 0.41%
+24,700
New +$858K
QDEL icon
46
QuidelOrtho
QDEL
$1.19B
$782K 0.4%
+6,100
New +$718K
APLT
47
DELISTED
Applied Therapeutics
APLT
$780K 0.4%
+37,500
New +$710K
F icon
48
Ford
F
$56.3B
$773K 0.4%
+52,000
New +$691K
VKTX icon
49
Viking Therapeutics
VKTX
$3.91B
$770K 0.4%
+128,500
New +$763K
TIGR
50
UP Fintech Holding
TIGR
$860M
$739K 0.38%
+25,500
New +$543K
1
2
3 4 5

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for ACT Capital Management, which disclosed 117 positions worth $195M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is STAAR Surgical: 231,600 shares worth $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, followed by Technology and Communication Services.

  • ACT Capital Management's largest Q2 2021 buy was STAAR Surgical: 231,600 shares worth $35.3M.
  • ACT Capital Management's ten largest holdings make up 57% of its $195M portfolio in Q2 2021.
  • ACT Capital Management disclosed 117 positions in Q2 2021, its first 13F filing on record.

Based on ACT Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.